There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Quest Diagnostics Incorporated (DGX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by +$1.07, or +0.88%, to $122.84. Volume reached 24,786 shares, with price reaching a high of $122.84 and a low of $122.84. The stock was recently discussed on Yahoo Finance as it revealed that WP’s Tyler Sanchez Is 1 of 30 College Students Nationwide Selected for American Heart Association’s Hispanic Serving Institution Scholar Program.
As a NYSE listed company, DGX falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $122.84 and fluctuated between $123.75 as its day high and $120.40 as its day low. The current market capitalization of Quest Diagnostics Incorporated is $14.27B. A total of 1.03 million shares were traded on the day, compared to an average of 830.13K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, DGX has seen 5 BUY and 2 SELL insider trades, representing the acquisition of 4,070 and the disposition of 4,000 shares. Over the last 12 months, there were 39 BUYs and 50 SELLs from insiders. Insiders purchased 697,878 shares during that period but sold 588,918.
In the most recent transaction, RING TIMOTHY M sold 2,000 shares of DGX for 125.02 per share on Sep 01. After the transaction, the Director now owns 23,933 company shares. In a previous transaction on Aug 01, RING TIMOTHY M sold 2,000 shares at 136.04 per share. DGX shares that Director owns now total 23,933.
Among the insiders who sold shares, RING TIMOTHY M disposed of 2,000 shares on Jul 01 at a per-share price of $133.47. This resulted in the Director holding 23,933 shares of DGX after the transaction. In another insider transaction, RUSCKOWSKI STEPHEN H sold 282,408 shares at $140.12 per share on May 24. Company shares held by the Chairman, CEO and President now total 334,833.
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Quest Diagnostics Incorporated pays an annual dividend of $2.64, resulting in a dividend yield of 2.15%, and it has a price to earnings (P/E) ratio of 10.22. DGX’s most recent ex-dividend date was 07/05/2022 when it declared a $0.66 quarterly dividend that was paid in cash on 07/20/2022. Previously, the company paid the dividend on 04/20/2022 with an ex-dividend date of 04/05/2022. The dividend was $0.66 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for DGX in the last 3 months, the mean price target is $143.36 with high estimates of $160.00 and low estimates of $129.00. In terms of 52-week highs and lows, DGX has a high of $174.16 and a low of $121.73.
As of this writing, DGX has an earnings estimate of $2.13 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $2.27 per share and a lower estimate of $2.01. The company reported an EPS of $2.36 in the last quarter, which was 4.42% higher than expectations of $2.26.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 18 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Underweight with a score of 3.55. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 12 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.